Page 18

Junio 2016

ARTÍCULOS DE INVESTIGACIÓN Valor pronóstico de la relación RAN/RAL en cáncer de mama - X. Mimica et al 4. Metzger-Filho O, Sun Z, Viale G, Price K N, Crivellari D, Snyder R D, et al. Patterns of Recurrence and outcome 696 according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX. J Clin Oncol 2013; 31 (25): 3083-90. 5. Okada F. Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms. Yonago Acta Med 2014; 57 (2): 65-72. 6. Baumgarten SC, Frasor J. Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol 2012; 26 (3): 360-71. 7. Roxburgh CSD, McMillan DC. Cancer and systemic inflammation: treat the tumour and treat the host. Br J Cancer. Nature Publishing Group; 2014; 110 (6): 1409- 12. 8. Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease specific survival in breast cancer patients. J Breast Cancer 2013; 16 (1): 55-9. 9. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13 (11): 759-71. 10. Urrejola GI, Bambs CE, Espinoza MA, Gellona J, Zúñiga AM, Molina ME, et al. An elevated neutrophil/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer. Rev Med Chile 2013; 141 (5): 602-8. 11. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol 2010; 17 (6): 1471-4. 12. Sánchez C, Acevedo F, Petric M, Galindo H, Domínguez F, León A, et al. Cáncer de mama metastásico. Caracterización de una cohorte según subtipos. Rev Med Chile 2014; 142 (4): 428-35. 13. Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 2014; 26 (1): 54-74. 14. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis. J. Natl. Cancer Inst 2014. p. dju124-dju124. 15. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009; 30 (7): 1073-81. 16. Simpson ER, Brown KA. Obesity and breast cancer: Role of inflammation and aromatase. J Mol Endocrinol 2013; 51 (3): T51-9. 17. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book 2013; 33: 46-51. 18. Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013; 30 (1): 432. 19. Chen J, Deng Q, Pan Y, He B, Ying H, Sun H, et al. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer. FEBS Open Bio 2015; 5: 502-7. 20. Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 2014; 26 (2): 259-71. 21. Nieto Y, Shpall EJ, McNiece IK, Nawaz S, Beaudet J, Rosinski S, et al. Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant. Clin Cancer Res 2004; 10 (15): 5076-86. 22. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers J-W, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012; 122 (1): 327-36. Rev Med Chile 2016; 144: 691-696


Junio 2016
To see the actual publication please follow the link above